|
⚲
|
| Keyboard |
| Markel Stacy
✚
|
|
|---|---|
| CIK # | 0001734780 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001734780] | |
| 4 | [0001734780] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Panacea Acquisition Corp | |
| Markel Stacy | |
| Rigel Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
|
2026-02-27 | Grant | 748,130 | $0.00 | |
|
Panacea Acquisition Corp NUVB
Class A Common Stock
|
2025-06-18 | Buy | 10,000 | $1.71 | 17,100 |
|
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
|
2025-02-28 | Grant | 500,000 | $0.00 | |
|
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
|
2024-02-29 | Grant | 500,000 | $0.00 | |
|
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
|
2023-02-28 | Grant | 500,000 | $0.00 | |
|
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
|
2022-08-29 | Grant | 450,000 | $0.00 | |
|
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
|
2022-02-28 | Grant | 500,000 | $0.00 | |
|
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
|
2021-02-10 | Grant | 398,935 | ||
|
Panacea Acquisition Corp NUVB
Stock Option (Right to Buy) · derivative
|
2021-02-10 | Grant | 254,810 | ||
|
Rigel Pharmaceuticals Inc RIGL
Employee Stock Option (right to buy) · derivative
|
2019-03-20 | Grant | 62,500 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Employee Stock Option (right to buy) · derivative
|
2019-01-23 | Grant | 137,500 | $0.00 | |
|
Rigel Pharmaceuticals Inc RIGL
Employee Stock Option (Right to Buy) · derivative
|
2018-03-21 | Grant | 125,000 | $0.00 |